Involvement of the Cytokine Receptor CD137 in Murine Hematopoiesis
CD137 and CD137 ligand are members of the tumor necrosis factor (TNF) receptor and TNF family, respectively. CD137 is expressed by cells in the bone marrow and CD137 ligand is expressed on hematopoietic progenitor cells. The interaction of CD137 and CD137 ligand induced proliferation and colony formation of hematopoietic progenitor cells and their differentiation to macrophages. Since CD137 is expressed on activated immune cells the CD137-induced myelopoiesis may take place during ongoing immune responses. However, in a steady-state condition the CD137 receptor/ligand system seems to inhibit myelopoiesis. Current data only indicate an involvement of CD137 and its ligand in myelopoiesis while other hematopoietic lineages are not affected.
KeywordsBone Marrow Cell CD137 Ligand Hematopoietic Progenitor Cell Osteoclast Progenitor Diacetate Succinimidyl
Part of this chapter is based on Jiang et al. . Copyright 2008. The American Association of Immunologists, Inc.
- 3.Coutinho LM, Gilleece HM, de Wynter EA, Will A, Testa GN (1993) Hematopoiesis: a practical approach. In Testa GN, Molineux G (eds). Oxford University Press, New York, 75–106Google Scholar
- 21.Niu L, Strahotin S, Hewes B, Zhang B, Zhang Y, Archer D, Spencer T, Dillehay D, Kwon B, Chen L, Vella TA, Mittler RS (2007) Cytokine-mediated disruption of lymphocyte trafficking, hemopoiesis, and induction of lymphopenia, anemia, and thrombocytopenia in anti-CD137-treated mice. J Immunol 178:4194–4213PubMedGoogle Scholar
- 22.Olofsson PS, Soderstrom LA, Wagsater D, Sheikine Y, Ocaya P, Lang F, Rabu C, Chen L, Rudling M, Aukrust P, Hedin U, Paulsson-Berne G, Sirsjo A, Hansson GK (2008) CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice. Circulation 117:1292–1301CrossRefPubMedGoogle Scholar
- 23.Saito K, Ohara N, Hotokezaka H, Fukumoto S, Yuasa K, Naito M, Fujiwara T, Nakayama K (2004) Infection-induced up-regulation of the costimulatory molecule 4-1BB in osteoblastic cells and its inhibitory effect on M-CSF/RANKL-induced in vitro osteoclastogenesis. J Biol Chem 279:13555–13563CrossRefPubMedGoogle Scholar